• SENSEX 76,295.36
    -322.08 (--0.42%)
  • BANKNIFTY 51,597.35
    249.30 (+0.49%)
  • Mazagon Dock
    2,750.00 2,929.98(%)
  • Tejas Networks
    902.70 1,495.10(%)
  • Hind.Aeronautics
    4,328.95 5,675.00(%)
  • Kalyan Jewellers
    497.15 337.00(%)
  • Adani Power
    538.00 896.75(%)
  • TCS
    3,396.10 3,396.10(%)
  • Reliance Industr
    1,234.55 1,156.00(%)
  • Bharat Electron
    288.30 340.35(%)
  • Persistent Sys
    4,764.75 3,232.60(%)
  • Vodafone Idea
    8.06 6.60(%)
  • Tata Motors
    652.80 606.20(%)
  • Infosys
    1,485.10 1,359.10(%)
  • Angel One
    2,475.00 3,502.60(%)
  • Jio Financial
    231.75 394.70(%)
  • HDFC Bank
    1,776.70 1,430.15(%)
  • Nippon ETF Liq.
    1,000.01 1,005.00(%)
  • Reliance Power
    44.44 54.25(%)
  • Zomato Ltd
    208.35 146.85(%)
  • ICICI Pru. BSE
    999.99 998.75(%)
  • Emcure Pharma
    1,025.75 911.75(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Krebs Biochemicals & Industries Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 3697.0
  • ISIN : INE268B01013
74.15 3 (4.36%)
  • As on 03 Apr 2025 (EOD)

  • Today’s Low

    70.51

  • Today’s High

    74.50

  • Open

    70.70

  • Perv Close

    71.05

  • 52W Low

    61.00

  • 52W High

    129.07

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    159.87

  • Div & Yield %

    0.00

  • Book Value(₹)

    -60.36

  • Debt-Equity Ratio

    4.36

  • AGM Date

    03-Apr-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    159.87

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    21.56

  • BV (₹)

    -60.40

  • Sales( ₹ in Cr.)

    50.42

  • NP (in Cr.)

    -19.73

  • NP Var(%)

    20.0

  • Div%

    0.0

  • CPS (₹)

    -6.00

  • EPS (₹)

    -9.20

  • Traded Value (₹ in Lakhs)

    160.54

  • 52 Week High

    129.07

  • 52 Week Low

    61.00

  • Price BSE

    74.0

  • Price NSE

    74.00

  • Market Capital( in Cr.)

    160.54

  • P/C Ratio

    -12.30

  • P/E Ratio

    -8.10

  • Price Vs.BV

    -9.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 50.42 52.13 59.70 53.70 33.41 47.76
Excise Duty 6.51 26.64 52.94 38.61 23.58 37.13
Net Sales 50.42 52.13 59.70 53.70 33.41 47.76
Other Income 0.45 0.62 1.16 0.62 0.37 0.33
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 50.87 52.75 60.86 54.32 33.78 48.09
EXPENDITURE :
Raw Materials 6.51 26.64 52.94 38.61 23.58 37.13
Power & Fuel Cost 6.51 26.64 52.94 38.61 23.58 37.13
Employee Cost 16.47 15.84 15.30 15.83 15.08 14.94
Other Manufacturing Expenses 0.11 0.17 0.11 0.24 0.39 0.25
Selling & Administrative Expenses 4.20 4.27 5.77 2.97 3.66 3.48
Miscellaneous Expenses 0.11 0.17 0.11 0.24 0.39 0.25
Less : Pre-operative Expenses Capitalised :
Total Expenditure 70.60 77.45 105.39 82.68 62.65 68.21
Operating Profit 31.77 21.96 31.88 26.28 17.05 15.80
Interest 4.69 2.97 5.39 6.28 5.93 6.24
Gross Profit -19.73 -24.69 -44.53 -28.36 -28.87 -20.01
Depreciation 6.77 6.56 6.30 5.12 4.68 4.40
Profit Before Tax -19.73 -24.69 -44.53 -28.36 -28.87 -20.01
Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit -19.73 -24.69 -44.53 -28.36 -28.87 -20.01
Extraordinary Items -19.73 -24.69 -44.53 -28.36 -28.87 -20.01
Adjusted Net Profit -19.73 -24.69 -44.53 -28.36 -28.87 -20.01
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -19.73 -24.69 -44.53 -28.36 -28.87 -20.01
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -9.16 -11.30 -20.81 -14.37 -17.90 -12.83
Book Value 0.00 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    72.74%

  • Public Share Holding

    27.26%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 10,705,195 49.65 10,705,195 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,978,939 23.09 4,958,539 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 15,684,134 72.74 15,663,734 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 522 0.00 522 1
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 106,300 0.49 105,000 4
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 106,822 0.50 105,522 5
2] Non Institution
Bodies Corporate 1,090,660 5.06 1,087,059 82
Clearing Members 0 0.00 0 0
Directors of their Relatives 105 0.00 105 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 219,603 1.02 219,603 98
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 142,760 0.66 142,760 209
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,920,260 8.91 1,610,260 27
Individuals holding nominal share capital up to Rs. 1 lakh 2,396,240 11.11 2,278,010 8,660
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 2 0.00 2 2
Sub Total 5,769,630 26.76 5,337,799 9,080
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 21,560,586 100.00 21,107,055 9,091

Company Background

Krebs Biochemicals & Industries LtdPharmaceuticals - Indian - Bulk Drugs

  • Krebs Biochemicals & Industries Ltd
  • BSE Code : 3697.0
  • ISIN : INE268B01013

  • Incorporation Year

    1991

  • Registered Office

    Kothapalli(V) Kasimkota(M)
    Anakapalli, Vishakapatnam,
    Andhra Pradesh-531031

  • Telephone

    91-040-6680 8040

  • FAX

  • Chairman

    R T Ravi

  • Managing Director

    Jitendra Shah

  • Company Secretary

    Keyur Doshi

  • Auditor

    Bhavani & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Krebs Biochemicals & Industries Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Krebs Biochem 74.46 50.87 50.42 -6.55 0.00
Abbott India 29,940.35 6,097.18 5,848.91 47.68 44.71
Astrazeneca Phar 8,092.00 1,330.33 1,295.53 208.61 33.26
P & G Health Ltd 5,295.80 1,166.89 1,151.26 37.16 39.76
Glaxosmi. Pharma 2,857.90 3,530.73 3,407.25 56.83 44.44
Cipla 1,495.15 17,645.00 16,574.34 25.63 20.10
Amrutanjan Healt 666.30 437.58 421.23 39.06 20.84
Fermenta Biotec. 305.85 315.24 307.09 28.99 4.10
Guj. Themis Bio. 282.25 174.19 169.82 58.44 44.82
Bliss GVS Pharma 126.20 638.96 605.46 28.88 11.19
Ambalal Sarabhai 40.33 11.70 3.81 17.24 1.92